Shobith Rangappa

28PUBLICATIONS
43CO-AUTHORS
Molecular targetsQuantum physics not elsewhere classifiedPredictive and prognostic markersBiologically active moleculesSignal transduction
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Apr 17, 2026
Pyrazoline-Imidazopyridine Hybrids as Beclin-1 Mimetics Driving Dual Apoptotic and Autophagy in Breast Cancer.

|Aug 01, 2025
Reply to: "The non-cytotoxic small molecule NPB does not inhibit BAD phosphorylation and forms colloidal aggregates".

Xi Zhang, Basappa Basappa, Peter E Lobie

|Feb 21, 2025
TFF3 facilitates dormancy of anti-estrogen treated ER+ mammary carcinoma.

Shu Chen, Xi Zhang, Basappa Basappa

|Feb 07, 2025
Inhibition of TFF3 synergizes with c-MET inhibitors to decrease the CSC-like phenotype and metastatic burden in ER+HER2+ mammary carcinoma.

Chuyu He, Xuejuan Wang, Yi-Shiou Chiou

|Jan 20, 2025
Discovery of 2-Pyrazolines That Inhibit the Phosphorylation of STAT3 as Nanomolar Cytotoxic Agents.

Tejaswini P Siddappa, Akshay Ravish, Zhang Xi

|Dec 10, 2024
TFF3 drives Hippo dependent EGFR-TKI resistance in lung adenocarcinoma.

Shuwei Zhang, Yan Qin Tan, Xi Zhang

Pageof 5

Frequent Collaborators

12 joint publications

Vijay Pandey

10 joint publications

Zhang Xi

8 joint publications

Peter E Lobie

7 joint publications

Kwang Seok Ahn